Global Recombinant Vaccines Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1881400
- Published On: Jul, 2020
- Category : Healthcare & Pharma
- Pages : 120
-
Recombinant or purified protein vaccines consist of protein antigens that have either been produced in a heterologous expression system (e.g., bacteria or yeast) or purified from large amounts of the pathogenic organism. The vaccinated person produces antibodies to the protein antigen, thus protecting him/her from disease.
Recombinant/purified protein vaccines are based on the concept that humoral immune responses mounted to an infection are often targeted toward specific localized regions on the surface of protein antigens known as epitopes. The recombinant proteins for vaccination are produced by expressing these immunogenic proteins using heterologous expression systems. The immunogenic protein antigens can also be purified from the infectious organism. Once purified, protein antigens, recombinant and endogenous, are administered with an adjuvant to boost the immune response. Administering just the most immunogenic protein or proteins from an infectious organisms as a vaccine produces a more targeted immune response. This strategy also eliminates the risk of active infection that can occur with live attenuated vaccines or even inactivated vaccines where inactivation is incomplete.
The Recombinant Vaccines market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Recombinant Vaccines industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Recombinant Vaccines market can be split based on product types, major applications, and important countries as follows:
Key players in the global Recombinant Vaccines market covered in Chapter 12:
Johnson & Johnson
Pfizer, Inc.
Protein Science Corporation
Merck & Co., Inc
Mitsubishi Tanabe Pharma Corporation
Emergent Bio Solutions, Inc.
Pfizer Inc.
Sanofi Pasteur SA
GlaxoSmithKline
Bayer AG
Serum Institute of India Pvt. Ltd
Green Cross Corporation
Abiomed
Daiichi Sankyo
In Chapter 4 and 14.1, on the basis of types, the Recombinant Vaccines market from 2015 to 2025 is primarily split into:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
In Chapter 5 and 14.2, on the basis of applications, the Recombinant Vaccines market from 2015 to 2025 covers:
Recombinant Human Vaccines
Animal Recombinant Vaccines
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Recombinant Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Recombinant Vaccines Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Recombinant Vaccines
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Recombinant Vaccines industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Recombinant Vaccines Market Size, 2015 – 2020
2.1.2 Global Recombinant Vaccines Market Size by Type, 2015 – 2020
2.1.3 Global Recombinant Vaccines Market Size by Application, 2015 – 2020
2.1.4 Global Recombinant Vaccines Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Recombinant Vaccines Analysis
3.2 Major Players of Recombinant Vaccines
3.3 Recombinant Vaccines Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Recombinant Vaccines
3.3.3 Labor Cost of Recombinant Vaccines3.4 Market Distributors of Recombinant Vaccines
3.5 Major Downstream Buyers of Recombinant Vaccines Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Recombinant Vaccines Market, by Type4.1 Global Recombinant Vaccines Value and Market Share by Type (2015-2020)
4.2 Global Recombinant Vaccines Production and Market Share by Type (2015-2020)
4.3 Global Recombinant Vaccines Value and Growth Rate by Type (2015-2020)
4.3.1 Global Recombinant Vaccines Value and Growth Rate of Subunit Recombinant Vaccines
4.3.2 Global Recombinant Vaccines Value and Growth Rate of Attenuated Recombinant Vaccines
4.3.3 Global Recombinant Vaccines Value and Growth Rate of Vector Recombinant Vaccines4.4 Global Recombinant Vaccines Price Analysis by Type (2015-2020)
5 Recombinant Vaccines Market, by Application5.1 Downstream Market Overview
5.2 Global Recombinant Vaccines Consumption and Market Share by Application (2015-2020)
5.3 Global Recombinant Vaccines Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2015-2020)
5.3.2 Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2015-2020)
6 Global Recombinant Vaccines Market Analysis by Regions6.1 Global Recombinant Vaccines Sales, Revenue and Market Share by Regions
6.1.1 Global Recombinant Vaccines Sales by Regions (2015-2020)
6.1.2 Global Recombinant Vaccines Revenue by Regions (2015-2020)6.2 North America Recombinant Vaccines Sales and Growth Rate (2015-2020)
6.3 Europe Recombinant Vaccines Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Recombinant Vaccines Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Recombinant Vaccines Sales and Growth Rate (2015-2020)
6.6 South America Recombinant Vaccines Sales and Growth Rate (2015-2020)
7 North America Recombinant Vaccines Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Recombinant Vaccines Sales, Revenue and Market Share by Countries
7.2.1 North America Recombinant Vaccines Sales by Countries (2015-2020)
7.2.2 North America Recombinant Vaccines Revenue by Countries (2015-2020)7.3 United States Recombinant Vaccines Sales and Growth Rate (2015-2020)
7.4 Canada Recombinant Vaccines Sales and Growth Rate (2015-2020)
7.5 Mexico Recombinant Vaccines Sales and Growth Rate (2015-2020)
8 Europe Recombinant Vaccines Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Recombinant Vaccines Sales, Revenue and Market Share by Countries
8.2.1 Europe Recombinant Vaccines Sales by Countries (2015-2020)
8.2.2 Europe Recombinant Vaccines Revenue by Countries (2015-2020)8.3 Germany Recombinant Vaccines Sales and Growth Rate (2015-2020)
8.4 UK Recombinant Vaccines Sales and Growth Rate (2015-2020)
8.5 France Recombinant Vaccines Sales and Growth Rate (2015-2020)
8.6 Italy Recombinant Vaccines Sales and Growth Rate (2015-2020)
8.7 Spain Recombinant Vaccines Sales and Growth Rate (2015-2020)
8.8 Russia Recombinant Vaccines Sales and Growth Rate (2015-2020)
9 Asia Pacific Recombinant Vaccines Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Recombinant Vaccines Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Recombinant Vaccines Sales by Countries (2015-2020)
9.2.2 Asia Pacific Recombinant Vaccines Revenue by Countries (2015-2020)9.3 China Recombinant Vaccines Sales and Growth Rate (2015-2020)
9.4 Japan Recombinant Vaccines Sales and Growth Rate (2015-2020)
9.5 South Korea Recombinant Vaccines Sales and Growth Rate (2015-2020)
9.6 India Recombinant Vaccines Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Recombinant Vaccines Sales and Growth Rate (2015-2020)
9.8 Australia Recombinant Vaccines Sales and Growth Rate (2015-2020)
10 Middle East and Africa Recombinant Vaccines Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Recombinant Vaccines Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Recombinant Vaccines Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Recombinant Vaccines Revenue by Countries (2015-2020)10.3 Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2015-2020)
10.4 UAE Recombinant Vaccines Sales and Growth Rate (2015-2020)
10.5 Egypt Recombinant Vaccines Sales and Growth Rate (2015-2020)
10.6 Nigeria Recombinant Vaccines Sales and Growth Rate (2015-2020)
10.7 South Africa Recombinant Vaccines Sales and Growth Rate (2015-2020)
11 South America Recombinant Vaccines Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Recombinant Vaccines Sales, Revenue and Market Share by Countries
11.2.1 South America Recombinant Vaccines Sales by Countries (2015-2020)
11.2.2 South America Recombinant Vaccines Revenue by Countries (2015-2020)11.3 Brazil Recombinant Vaccines Sales and Growth Rate (2015-2020)
11.4 Argentina Recombinant Vaccines Sales and Growth Rate (2015-2020)
11.5 Columbia Recombinant Vaccines Sales and Growth Rate (2015-2020)
11.6 Chile Recombinant Vaccines Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Basic Information
12.1.2 Recombinant Vaccines Product Introduction
12.1.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-202012.2 Pfizer, Inc.
12.2.1 Pfizer, Inc. Basic Information
12.2.2 Recombinant Vaccines Product Introduction
12.2.3 Pfizer, Inc. Production, Value, Price, Gross Margin 2015-202012.3 Protein Science Corporation
12.3.1 Protein Science Corporation Basic Information
12.3.2 Recombinant Vaccines Product Introduction
12.3.3 Protein Science Corporation Production, Value, Price, Gross Margin 2015-202012.4 Merck & Co., Inc
12.4.1 Merck & Co., Inc Basic Information
12.4.2 Recombinant Vaccines Product Introduction
12.4.3 Merck & Co., Inc Production, Value, Price, Gross Margin 2015-202012.5 Mitsubishi Tanabe Pharma Corporation
12.5.1 Mitsubishi Tanabe Pharma Corporation Basic Information
12.5.2 Recombinant Vaccines Product Introduction
12.5.3 Mitsubishi Tanabe Pharma Corporation Production, Value, Price, Gross Margin 2015-202012.6 Emergent Bio Solutions, Inc.
12.6.1 Emergent Bio Solutions, Inc. Basic Information
12.6.2 Recombinant Vaccines Product Introduction
12.6.3 Emergent Bio Solutions, Inc. Production, Value, Price, Gross Margin 2015-2020
12.7 Pfizer Inc.
12.7.1 Pfizer Inc. Basic Information
12.7.2 Recombinant Vaccines Product Introduction
12.7.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
12.8 Sanofi Pasteur SA
12.8.1 Sanofi Pasteur SA Basic Information
12.8.2 Recombinant Vaccines Product Introduction
12.8.3 Sanofi Pasteur SA Production, Value, Price, Gross Margin 2015-2020
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Basic Information
12.9.2 Recombinant Vaccines Product Introduction
12.9.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-202012.10 Bayer AG
12.10.1 Bayer AG Basic Information
12.10.2 Recombinant Vaccines Product Introduction
12.10.3 Bayer AG Production, Value, Price, Gross Margin 2015-2020
12.11 Serum Institute of India Pvt. Ltd
12.11.1 Serum Institute of India Pvt. Ltd Basic Information
12.11.2 Recombinant Vaccines Product Introduction
12.11.3 Serum Institute of India Pvt. Ltd Production, Value, Price, Gross Margin 2015-2020
12.12 Green Cross Corporation
12.12.1 Green Cross Corporation Basic Information
12.12.2 Recombinant Vaccines Product Introduction
12.12.3 Green Cross Corporation Production, Value, Price, Gross Margin 2015-2020
12.13 Abiomed
12.13.1 Abiomed Basic Information
12.13.2 Recombinant Vaccines Product Introduction
12.13.3 Abiomed Production, Value, Price, Gross Margin 2015-2020
12.14 Daiichi Sankyo
12.14.1 Daiichi Sankyo Basic Information
12.14.2 Recombinant Vaccines Product Introduction
12.14.3 Daiichi Sankyo Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Recombinant Vaccines Market Forecast14.1 Global Recombinant Vaccines Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Subunit Recombinant Vaccines Market Value and Volume Forecast (2020-2025)
14.1.2 Attenuated Recombinant Vaccines Market Value and Volume Forecast (2020-2025)
14.1.3 Vector Recombinant Vaccines Market Value and Volume Forecast (2020-2025)14.2 Global Recombinant Vaccines Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Recombinant Human Vaccines Market Value and Volume Forecast (2020-2025)
14.2.2 Animal Recombinant Vaccines Market Value and Volume Forecast (2020-2025)14.3 Recombinant Vaccines Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Recombinant Vaccines
Table Product Specification of Recombinant Vaccines
Table Recombinant Vaccines Key Market Segments
Table Key Players Recombinant Vaccines Covered
Figure Global Recombinant Vaccines Market Size, 2015 – 2025
Table Different Types of Recombinant Vaccines
Figure Global Recombinant Vaccines Value ($) Segment by Type from 2015-2020
Figure Global Recombinant Vaccines Market Share by Types in 2019
Table Different Applications of Recombinant Vaccines
Figure Global Recombinant Vaccines Value ($) Segment by Applications from 2015-2020
Figure Global Recombinant Vaccines Market Share by Applications in 2019
Figure Global Recombinant Vaccines Market Share by Regions in 2019
Figure North America Recombinant Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Europe Recombinant Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Recombinant Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Recombinant Vaccines Production Value ($) and Growth Rate (2015-2020)
Figure South America Recombinant Vaccines Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Recombinant Vaccines
Table Upstream Raw Material Suppliers of Recombinant Vaccines with Contact Information
Table Major Players Headquarters, and Service Area of Recombinant Vaccines
Figure Major Players Production Value Market Share of Recombinant Vaccines in 2019
Table Major Players Recombinant Vaccines Product Types in 2019
Figure Production Process of Recombinant Vaccines
Figure Manufacturing Cost Structure of Recombinant Vaccines
Figure Channel Status of Recombinant Vaccines
Table Major Distributors of Recombinant Vaccines with Contact Information
Table Major Downstream Buyers of Recombinant Vaccines with Contact Information
Table Global Recombinant Vaccines Value ($) by Type (2015-2020)
Table Global Recombinant Vaccines Value Share by Type (2015-2020)
Figure Global Recombinant Vaccines Value Share by Type (2015-2020)
Table Global Recombinant Vaccines Production by Type (2015-2020)
Table Global Recombinant Vaccines Production Share by Type (2015-2020)
Figure Global Recombinant Vaccines Production Share by Type (2015-2020)
Figure Global Recombinant Vaccines Value ($) and Growth Rate of Subunit Recombinant Vaccines (2015-2020)
Figure Global Recombinant Vaccines Value ($) and Growth Rate of Attenuated Recombinant Vaccines (2015-2020)
Figure Global Recombinant Vaccines Value ($) and Growth Rate of Vector Recombinant Vaccines (2015-2020)
Figure Global Recombinant Vaccines Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Recombinant Vaccines Consumption by Application (2015-2020)
Table Global Recombinant Vaccines Consumption Market Share by Application (2015-2020)
Figure Global Recombinant Vaccines Consumption Market Share by Application (2015-2020)
Figure Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2015-2020)
Figure Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2015-2020)
Figure Global Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Global Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table Global Recombinant Vaccines Sales by Regions (2015-2020)
Table Global Recombinant Vaccines Sales Market Share by Regions (2015-2020)
Table Global Recombinant Vaccines Revenue (M USD) by Regions (2015-2020)
Table Global Recombinant Vaccines Revenue Market Share by Regions (2015-2020)
Table Global Recombinant Vaccines Revenue Market Share by Regions in 2015
Table Global Recombinant Vaccines Revenue Market Share by Regions in 2019
Figure North America Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Europe Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure South America Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table North America Recombinant Vaccines Sales by Countries (2015-2020)
Table North America Recombinant Vaccines Sales Market Share by Countries (2015-2020)
Table North America Recombinant Vaccines Revenue (M USD) by Countries (2015-2020)
Table North America Recombinant Vaccines Revenue Market Share by Countries (2015-2020)
Figure United States Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Canada Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Mexico Recombinant Vaccines Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table Europe Recombinant Vaccines Sales by Countries (2015-2020)
Table Europe Recombinant Vaccines Sales Market Share by Countries (2015-2020)
Table Europe Recombinant Vaccines Revenue (M USD) by Countries (2015-2020)
Table Europe Recombinant Vaccines Revenue Market Share by Countries (2015-2020)
Figure Germany Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure UK Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure France Recombinant Vaccines Sales and Growth (2015-2020)
Figure Italy Recombinant Vaccines Sales and Growth (2015-2020)
Figure Spain Recombinant Vaccines Sales and Growth (2015-2020)
Figure Russia Recombinant Vaccines Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Recombinant Vaccines Sales by Countries (2015-2020)
Table Asia Pacific Recombinant Vaccines Sales Market Share by Countries (2015-2020)
Table Asia Pacific Recombinant Vaccines Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Recombinant Vaccines Revenue Market Share by Countries (2015-2020)
Figure China Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Japan Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure South Korea Recombinant Vaccines Sales and Growth (2015-2020)
Figure India Recombinant Vaccines Sales and Growth (2015-2020)
Figure Southeast Asia Recombinant Vaccines Sales and Growth (2015-2020)
Figure Australia Recombinant Vaccines Sales and Growth (2015-2020)
Figure Middle East Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table Middle East Recombinant Vaccines Sales by Countries (2015-2020)
Table Middle East and Africa Recombinant Vaccines Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Recombinant Vaccines Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure UAE Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Egypt Recombinant Vaccines Sales and Growth (2015-2020)
Figure Nigeria Recombinant Vaccines Sales and Growth (2015-2020)
Figure South Africa Recombinant Vaccines Sales and Growth (2015-2020)
Figure South America Recombinant Vaccines Revenue (M USD) and Growth (2015-2020)
Table South America Recombinant Vaccines Sales by Countries (2015-2020)
Table South America Recombinant Vaccines Sales Market Share by Countries (2015-2020)
Table South America Recombinant Vaccines Revenue (M USD) by Countries (2015-2020)
Table South America Recombinant Vaccines Revenue Market Share by Countries (2015-2020)
Figure Brazil Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Argentina Recombinant Vaccines Sales and Growth Rate (2015-2020)
Figure Columbia Recombinant Vaccines Sales and Growth (2015-2020)
Figure Chile Recombinant Vaccines Sales and Growth (2015-2020)
Figure Top 3 Market Share of Recombinant Vaccines Companies in 2019
Figure Top 6 Market Share of Recombinant Vaccines Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Product Introduction
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Protein Science Corporation Profile
Table Protein Science Corporation Product Introduction
Figure Protein Science Corporation Production and Growth Rate
Figure Protein Science Corporation Value ($) Market Share 2015-2020
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Product Introduction
Figure Merck & Co., Inc Production and Growth Rate
Figure Merck & Co., Inc Value ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Product Introduction
Figure Mitsubishi Tanabe Pharma Corporation Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Value ($) Market Share 2015-2020
Table Emergent Bio Solutions, Inc. Profile
Table Emergent Bio Solutions, Inc. Product Introduction
Figure Emergent Bio Solutions, Inc. Production and Growth Rate
Figure Emergent Bio Solutions, Inc. Value ($) Market Share 2015-2020
Table Pfizer Inc. Profile
Table Pfizer Inc. Product Introduction
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Sanofi Pasteur SA Profile
Table Sanofi Pasteur SA Product Introduction
Figure Sanofi Pasteur SA Production and Growth Rate
Figure Sanofi Pasteur SA Value ($) Market Share 2015-2020
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Product Introduction
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table Bayer AG Profile
Table Bayer AG Product Introduction
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Serum Institute of India Pvt. Ltd Profile
Table Serum Institute of India Pvt. Ltd Product Introduction
Figure Serum Institute of India Pvt. Ltd Production and Growth Rate
Figure Serum Institute of India Pvt. Ltd Value ($) Market Share 2015-2020
Table Green Cross Corporation Profile
Table Green Cross Corporation Product Introduction
Figure Green Cross Corporation Production and Growth Rate
Figure Green Cross Corporation Value ($) Market Share 2015-2020
Table Abiomed Profile
Table Abiomed Product Introduction
Figure Abiomed Production and Growth Rate
Figure Abiomed Value ($) Market Share 2015-2020
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Product Introduction
Figure Daiichi Sankyo Production and Growth Rate
Figure Daiichi Sankyo Value ($) Market Share 2015-2020
Table Market Driving Factors of Recombinant Vaccines
Table Merger, Acquisition and New Investment
Table Global Recombinant Vaccines Market Value ($) Forecast, by Type
Table Global Recombinant Vaccines Market Volume Forecast, by Type
Figure Global Recombinant Vaccines Market Value ($) and Growth Rate Forecast of Subunit Recombinant Vaccines (2020-2025)
Figure Global Recombinant Vaccines Market Volume ($) and Growth Rate Forecast of Subunit Recombinant Vaccines (2020-2025)
Figure Global Recombinant Vaccines Market Value ($) and Growth Rate Forecast of Attenuated Recombinant Vaccines (2020-2025)
Figure Global Recombinant Vaccines Market Volume ($) and Growth Rate Forecast of Attenuated Recombinant Vaccines (2020-2025)
Figure Global Recombinant Vaccines Market Value ($) and Growth Rate Forecast of Vector Recombinant Vaccines (2020-2025)
Figure Global Recombinant Vaccines Market Volume ($) and Growth Rate Forecast of Vector Recombinant Vaccines (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Recombinant Human Vaccines (2020-2025)
Figure Market Volume and Growth Rate Forecast of Recombinant Human Vaccines (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Animal Recombinant Vaccines (2020-2025)
Figure Market Volume and Growth Rate Forecast of Animal Recombinant Vaccines (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Recombinant Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
During the projected year from 2024 to 2029, the Global Recombinant Vaccines Market is expected to grow at a CAGR of xx%.
The value of the Global Recombinant Vaccines Market is estimated to be USD XXX million.
This latest research publication on the Global Recombinant Vaccines Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.
